Human papillomavirus (HPV) vaccination is cancer prevention for childhood cancer survivors

Abstract

Childhood cancer survivors are at high risk for developing subsequent human papillomavirus (HPV)‐associated cancers. In this issue, Henderson and colleagues examine risk factors for subsequent malignant neoplasms associated with HPV among enrollees in the Childhood Cancer Survivor Study and report that improved, targeted efforts to increase HPV vaccination and HPV‐related surveillance among childhood cancer survivors are needed.

Reducing Cancer Risk Through Primary Prevention Activities Among Children: A Demonstration Project

“…7 Although HBV vaccine is recommended for all infants, nearly 10% of all children have not received HBV vaccination by age 24 months. 8 Primary prevention interventions for cancer prevention among children, including HPV and HBV vaccination and sun safety programs, [9][10][11][12] are recommended by several organizations, including the Advisory Committee on Immunization Practices, 2,3 the Community Guide, 13 the National Academies of Sciences, Engineering, and Medicine, 14 the American Academy of Pediatrics, 15 and Healthy People 2030. 16 The National Comprehensive Cancer Control Program (NCCCP) supports cancer control activities in the United States, including primary prevention, in all 50 states, the District of Columbia, 8 associated Pacific islands/territories, and 7 tribes and tribal organizations.…”

“…Although HBV vaccine is recommended for all infants, nearly 10% of all children have not received HBV vaccination by age 24 months 8. Primary prevention interventions for cancer prevention among children, including HPV and HBV vaccination and sun safety programs,9–12 are recommended by several organizations, including the Advisory Committee on Immunization Practices,2,3 the Community Guide,13 the National Academies of Sciences, Engineering, and Medicine,14 the American Academy of Pediatrics,15 and Healthy People 2030 16…”